A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Clinical trial NCT07160725 · RECRUITING
Trial details
- NCT number
- NCT07160725
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2028-07-31
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.